Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein

[1]  R. Peltier,et al.  GR38032F, a serotonin 5-HT3 antagonist, fails to alter cocaine self-administration in rats , 1991, Pharmacology Biochemistry and Behavior.

[2]  C. Dourish,et al.  Cholecystokinin and anxiety. , 1990, Trends in pharmacological sciences.

[3]  J. Droz,et al.  Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. , 1990, The New England journal of medicine.

[4]  G. Di Chiara,et al.  Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. , 1989, European journal of pharmacology.

[5]  M. Mintz,et al.  Chronic l-Dopa fails to lessen rebound enhancement of self-stimulation after chronic haloperidol , 1988, Pharmacology Biochemistry and Behavior.

[6]  B. Costall,et al.  The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist , 1988, British journal of pharmacology.

[7]  B. Costall,et al.  Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain , 1987, British journal of pharmacology.

[8]  J. A. Deutsch,et al.  Dietary control and the stomach , 1983, Progress in Neurobiology.

[9]  J. Crawley,et al.  Rapid development of tolerance to the behavioural actions of cholecystokinin , 1983, Nature.

[10]  J. Liebman.  Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology , 1983, Neuroscience & Biobehavioral Reviews.

[11]  G. P. Smith,et al.  Cholecystokinin decreases food intake in rats. , 1973, Journal of comparative and physiological psychology.